Literature DB >> 2369188

Reoperation in the intensive care unit.

G C Kaiser1, K S Naunheim, A C Fiore, H H Harris, L R McBride, D G Pennington, H B Barner, V L Willman.   

Abstract

From July 1, 1984, through June 30, 1989, after 1,259 open heart operations, 110 patients (8.7%) underwent 162 early reoperations either in the intensive care unit (144 procedures) or in the operating room (26 procedures). Reexploration for bleeding (49 procedures) (3.9%) and intraaortic balloon removal (50 procedures) (4.0%) were the two most common procedures. Ninety percent and 96% of these procedures, respectively, were performed in the intensive care unit. Mediastinal infections occurred in 4 (6.1%) of 66 patients undergoing repeat mediastinal operations for all indications. No infection occurred after reexploration for bleeding nor did mediastinal infection occur after reoperation in the intensive care unit. Postoperative death in these 110 patients was not related to reoperation except possibly in the case of 1 patient (0.9%). Average transit time to and from the operating room for patients returned there for reoperation was 89.7 minutes. Charges for procedures performed in the operating room were at least twice as great as for those performed in the intensive care unit. This experience supports expanded use of reoperation in the intensive care unit, as it is safe, effective, economical, and convenient.

Entities:  

Mesh:

Year:  1990        PMID: 2369188     DOI: 10.1016/0003-4975(90)90863-2

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  2 in total

1.  Planned cardiac reexploration in the intensive care unit is a safe procedure.

Authors:  Damien J LaPar; James M Isbell; Daniel P Mulloy; Matthew L Stone; John A Kern; Gorav Ailawadi; Irving L Kron
Journal:  Ann Thorac Surg       Date:  2014-08-28       Impact factor: 4.330

2.  Medico-legal autopsy in postoperative hemodynamic collapse following coronary artery bypass surgery.

Authors:  Janne P Karhunen; Pekka J Karhunen; Peter M Raivio; Eero I T Sihvo; Tiina L S Vainikka; Ulla-Stina Salminen
Journal:  Forensic Sci Med Pathol       Date:  2010-09-07       Impact factor: 2.007

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.